Review
Copyright ©The Author(s) 2020.
World J Orthop. Dec 18, 2020; 11(12): 559-572
Published online Dec 18, 2020. doi: 10.5312/wjo.v11.i12.559
Table 1 Single stage revision outcomes for total knee arthroplasty and total hip arthroplasty
Ref.
Year
PJI
Cases
Reinfection
Follow-up (in year)
Freeman et al[47]1985Knee802
Göksan et al[48]1992Knee182 (11%)5
Scott et al[49]1993Knee103 (30%)
Silva et al[50]2002Knee374 (11%)5
Buechel et al[51]2004Knee222 (9%)10
Whiteside et al[52]2011Knee181 (6%)5.2
Parkinson et al[53]2011Knee2202
Singer et al[54]2012Knee633 (5%)3
Klatte et al[55]2014Knee41 (25%)2.1
Tibrewal et al[13]2014Knee501 (2%)10.5
Haddad et al[14]2015Knee2806.5
Labruyère et al[56]2015Knee905
Holland et al[57]2019Knee261 (4%)5.3
Siddiqi et al[58]2019TKA578 (14%)4.4
Abdelaziz et al[59]2020TKA728 (11%)4.2
Ji et al[60]2020Both515 (10%)4.4
Carlsson et al[61]1978Hip7717 (22%)
Hughes et al[62]1979Hip134 (31%)
Buchholz et al[2]1981Hip640130 (20%)4.3
Miley et al[63]1982Hip476 (13%)4
Weber et al[64]1986Hip82 (25%)6
Wroblewski et al[4]1986Hip1029 (9%)3.2
Sanzén et al[65]1988Hip10225 (25%)7
Hope et al[66]1989Hip729 (13%)3.75
Raut et al[67]1994Hip578 (14%)7.3
Mulcahy et al[68]1996Hip1504
Ure et al[69]1998Hip22010.5
Callaghan et al[6]1999Hip242 (8%)10
Rudelli et al[70]2008Hip322 (6%)5
Winkler et al[71]2008Hip373 (8%)4.4
Yoo et al[72]2008Hip121 (8%)7.2
Oussedik et al[39]2010Hip1106.8
De Man et al[40]2011Hip2203.8
Klouche et al[11]2012Hip3802
Choi et al[73]2013Hip173 (18%)5.1
Hansen et al[26]2013Hip278 (30%)2.25
Bori et al[46]2014Hip241 (4%)3.6
Jenny et al[74]2014Hip6517 (26%)5
Klatte et al[55]2014Hip602.1
Wolf et al[27]2014Hip3724 (65%)2
Zeller et al[5]2014Hip1578 (5%)3.4
Ebied et al[75]2016Hip331 (3%)6
Ilchman et al[76]2016Hip3906.6
Born et al[77]2016Hip2807
Lange et al[78]2017Hip565 (91%)4
Whiteside et al[79]2017Hip211 (95%)5.2
Zahar et al[80]2018Hip855 (6%)10.5
Bori et al[81]2018Hip191 (5%)
Wolff et al[82]2019Hip261 (96%)15
Ji et al[24]2019Hip11112 (11%)4.8
Table 2 Bactericidal antibiotics vs bacteriostatic antibiotics
Bactericidal antibiotics
Bacteriostatic
Aminoglycosides, cephalosporins, fluoroquinolones, metronidazole, penicillin, vancomycinChloramphenicol, clindamycin, erythromycin, sulfamethoxazole, tetracycline, trimethoprim
Table 3 International Consensus Meeting 2018 Guidelines for prosthetic joint infection for hip and knee arthroplasty
Major criteria
Two positive cultures of the same organism / Sinus tract with communication to the joint or prosthesis
Minor criteria
CriteriaAcute thresholdChronic thresholdScore
CRP (mg/L) or D Dimer (ug/L)100; unknown10; 8602
ESR (mm/h)No role301
Synovial WBC or leukocyte esterase or alpha defensin10000; ++; 1.03000; ++; 1.02
Synovial PMN %90702
Single positive culture2
Positive histology3
Positive intraoperative purulence3
Table 4 McPherson host class comorbidities
Systemic host compromising factors
Age ≥ 80 yrAlcoholismChronic cellulitis or dermatitis
Chronic indwelling catheterMalnutrition (albumin < 3 g/dL)Current nicotine use
DiabetesHepatic insuffiencyImmunosuppressive drugs
Malignancy (history or active)Pulmonary insuffiencyRenal failure on dialysis
Systemic inflammatory diseaseSystemic immune compromised disease or infection (HIV, AIDS)
Table 5 International consensus meeting indications and contra-indications for single stage revision for prosthetic joint infection
Indications
Contra-indications
Non-immunocompromised hostSevere damage to soft tissues were direct closure not possible or inexcisable complex sinus tract with old scar
Absence of systemic sepsisCulture negative PJI
Minimal bone/soft tissue loss allowing primary closureInability to perform radical debridement
Isolation of pathologic organism preoperativelyUnable to give local antibiotic treatment
Known sensitivities to bactericidal treatmentNo proper bone stock available for fixation